Triple-Negative Breast Cancer: Latasha’s Story

A survivor of triple-negative breast cancer, Latasha Jordan, and an expert breast oncologist, Aditya Bardia, MD, MPH, provide key insights into the patient experience in triple-negative breast cancer and highlight the role of clinical trials in the current treatment landscape.

EP. 1: Initial Diagnosis of Triple-Negative Breast Cancer

June 15th 2021

Latasha Jordan, a triple-negative breast cancer survivor, discusses challenges she faced with her symptoms and diagnosis, and Aditya Bardia, M.D., MPH, reviews the typical diagnostic work-up used to determine a treatment approach.

EP. 2: Neoadjuvant Chemotherapy for TNBC

August 17th 2021

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

EP. 3: Surgical Options for Triple-Negative Breast Cancer

August 17th 2021

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

EP. 4: Active Surveillance for Disease Progression in TNBC

August 17th 2021

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

EP. 5: Considerations for Referral After Progression of TNBC

August 17th 2021

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

EP. 6: The ASCENT 3 Trial of Sacituzumab Govitecan for TNBC

August 17th 2021

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

EP. 7: Safety and Efficacy of Sacituzumab Govitecan

August 17th 2021

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

EP. 8: Social Support Systems for Patients With TNBC

August 17th 2021

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

EP. 9: Advice for Future Patients and Caregivers in TNBC

August 17th 2021

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.